Efficacy of esketamine nasal spray over quetiapine extended release over the short and long term: sensitivity analyses of ESCAPE-TRD, a randomised phase IIIb clinical trial - ERRATUM

Allan H Young; Pierre-Michel Llorca; Andrea Fagiolini; Peter Falkai; Narcís Cardoner; René E Nielsen; Ola Blomqvist; Yordan Godinov; Benoît Rive; Joris Diels; Siobhán Mulhern-Haughey; Andreas Reif

doi:10.1192/bjp.2025.10308

Efficacy of esketamine nasal spray over quetiapine extended release over the short and long term: sensitivity analyses of ESCAPE-TRD, a randomised phase IIIb clinical trial - ERRATUM

Br J Psychiatry. 2025 Jun 9:1-2. doi: 10.1192/bjp.2025.10308. Online ahead of print.

Authors

Allan H Young, Pierre-Michel Llorca, Andrea Fagiolini, Peter Falkai, Narcís Cardoner, René E Nielsen, Ola Blomqvist, Yordan Godinov, Benoît Rive, Joris Diels, Siobhán Mulhern-Haughey, Andreas Reif

PMID: 40488357
DOI: 10.1192/bjp.2025.10308

No abstract available

Keywords: Esketamine nasal spray; erratum; long-term treatment; quetiapine extended release; sensitivity analysis; treatment resistant depression.

Publication types

Published Erratum